STAAR Surgical Generates Cash From Operations During Seco...(17836 46% ...),Health

Date:8/3/2009

17,836 46% ------ ------ ------ ------ Gross profit 56% 21,003 50% 19,289 1,500 20,789 54% ------ ------ ----- ------ Selling, general and administrative expenses: General and admini- strative 22% 8,137 21% 7,961 - 7,961 21% Marketing and selling 32% 11,811 37% 14,113 - 14,113 37% Research and development 8% 2,853 11% 4,075 - 4,075 11% Loss on settlement of pre-existing distribution arrangement - 10% 3,850 (3,850) - 0% --- -- ----- ----- --- Total selling, general and administrative expenses: 61% 22,801 78% 29,999 (3,850) 26,149 68% ------ -- ------ ----- ------ Operating loss -5% (1,798) -28% (10,710) 5,350 (5,360) -14% ----- -- ------ ----- ----- Other income (expense): 0% Interest income 0% 8 0% 91 - 91 0% Interest expense -2% (632) -1% (423) - (423) -1% Gain on foreign currency 1% 197 0% 144 - 144 0% Other income, net 1% 191 0% 67 - 67 0% -- --- -- Total other (expense) income, net -1% (236) 0% (121) - (121) 0% --- --- --- --- L
'/>"/>

SOURCE STAAR Surgical Company Copyright©2009 PR Newswire. All rights reserved

1 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
Related medicine news :

1. STAAR Surgical to Present at BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York
2. Review of STAARs Application for the Visian(R) Toric Implantable Collamer(R) Lens by FDA to Resume
3. Review of STAARs Application for the Visian(R) Toric Implantable Collamer(R) Lens by FDA to Resume
4. STAAR Surgical Announces Second Quarter 2009 Earnings Release Date And Conference Call
5. Richard A. Meier Appointed to STAAR Surgical Board of Directors
6. STAAR Surgical Completes Common Stock Offering
7. STAAR Surgical Receives Japanese Clearance for the KS-Ni Preloaded IOL Injector System
8. STAAR Surgical Announces First Quarter 2009 Earnings Release Date and Conference Call
9. STAAR Surgical Reports 14% Fourth Quarter Revenue Growth
10. STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer(R) Material for Accommodating Intraocular Lenses
11. STAAR Surgical Reports 33% Third Quarter Revenue Growth